Siegfried Holding AG (SFZN.SW) stock analysis

In our weekly check, Siegfried Holding AG is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3.

About Siegfried Holding AG

Siegfried Holding AG is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Switzerland, listed on SIX as SFZN.SW.

What our checks show for SFZN.SW

Red flags

• The stock has fallen as much as 73% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 7.3 years.
• Pay in shares equals 78.2% of free cash flow: it dilutes shareholders.

Warning signs

• Revenue grew only 2.6% a year over the last 3 years.
• Earnings per share fell 53% a year over the last 3 years.
• Free cash flow is only 0.8% of revenue.
• Free cash flow covers the dividend only 0.7 times.
• Thinly traded (about 110 thousand shares a day): buying and selling can move the price.

Strengths

• Operating profit covers interest 35.7 times over.
• The net margin rose by 4 points over 5 years, to 12.7%.
• The gross margin is 26.5% and has risen by 4.8 points: pricing power is holding.
• Operating cash flow is 1.32x net profit: the profit arrives as real cash.

Similar companies

BHC · HIK.L · HCM · INDV · PRGO · ALVO

Questions

What grade does Siegfried Holding AG (SFZN.SW) have?

In our weekly check, Siegfried Holding AG is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 17 pass, warnings: 5, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SFZN.SW stock?

This week's biggest flags for Siegfried Holding AG: Deep past fall, Slow recovery after falls, Heavy stock pay. In total 8 of 25 checks show a warning or a red flag.

What does Siegfried Holding AG do?

Siegfried Holding AG is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in Switzerland, listed on SIX as SFZN.SW.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis